HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS- A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73064-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)73064-9/fulltext
Title :
HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS- A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73064-9&doi=10.1016/S1098-3015(11)73064-9
First page :
A504
Section Title :
RESEARCH PODIUM ABSTRACTS
Open access? :
No
Section Order :
1226